Trial sponsors and CROs must do more to recruit older people, says EU group

By Gareth Macdonald

- Last updated on GMT

Related tags: European union

Clinical trials are often biased against the recruitment of older people says the European Union's PREDICT group, which has launched a charter designed to protect such patients' right to take part.

Peter Crome from Keele University, UK told Outsourcing-pharma that this under representation means evidence of a drug’s efficacy in older people is an extrapolation of data from trials in younger people, which may not necessarily be applicable.

Professor Crome explained that recognition of this trend was the key motivation for the development of the new PREDICT charter, which was launched last week in a project coordinated by the Medical Economics and Research Centre (MERCS).

Professor Crome also said that sponsors and contract research organisations (CRO) can play more of a role by, for example, working with researchers who have access to older people, or by making greater use of home visits that make participation in trials less time intensive.

Related news

Show more

Related products

show more

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Baxter BioPharma Solutions | 05-Nov-2018 | Technical / White Paper

Recent market reports suggest increasing product niches, which may lead to decreasing numbers of units per product, making dedicated facilities less practical....

Baxter’s Oncology Contract Manufacturing

Baxter’s Oncology Contract Manufacturing

Baxter BioPharma Solutions | 29-Aug-2018 | Product Brochure

Baxter BioPharma Solutions’ FOYA award-winning facility in Halle/Westfalen, Germany, offers state-of-the-art parenteral cGMP manufacturing at one location,...

Related suppliers

Follow us

Featured Events

View more

Products

View more

Webinars